Literature DB >> 22988923

Characteristics of achalasia subtypes in untreated Chinese patients: a high-resolution manometry study.

Min Min1, Li Hua Peng, Yun Sheng Yang, Xiao Hua Hou, Rong Bin Guo, Wei Feng Wang, Gang Sun, Xiao Xiao Wang.   

Abstract

OBJECTIVE: To evaluate and compare the clinical characteristics, manometric results and treatment outcomes of different subtypes of achalasia in untreated Chinese patients using high-resolution esophageal manometry.
METHODS: A total of 75 achalasia patients and 34 healthy controls were enrolled in the study, and three achalasia subtypes were determined based on the Chicago classification. Clinical characteristics, manometric and treatment outcomes were compared.
RESULTS: In all, 25 patients were classified as type I, 46 as type II and 4 as type III. The mean overall length of lower esophageal sphincter (LES) in type III was significantly longer than those in the controls and type I patients (P < 0.05), and abdominal LES length was significantly longer in type III than those in controls, type I and type II patients. All subtypes of achalasia had higher resting and residual LES pressures than those found in healthy controls (P < 0.05). Resting upper esophageal sphincter (UES) pressure in type III patients was significantly lower than those in healthy controls and type I patients, whereas types I and II patients had higher residual UES pressures compared with healthy controls (P < 0.05). Type II patients had a better response to the treatment than type I and III patients.
CONCLUSIONS: Type II is more common in untreated Chinese achalasia patients, and type II patients had better treatment outcomes than other types of patients. Large-sample multicenter trials are necessary in the future.
© 2012 The Authors. Journal of Digestive Diseases © 2012 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22988923     DOI: 10.1111/j.1751-2980.2012.00622.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  12 in total

1.  Upper Esophageal Sphincter Motility and Thoracic Pressure are Determinants of Pressurized Waves in Achalasia Subtypes According to the Chicago Classification.

Authors:  Alexandre Anefalos; Fernando A M Herbella; Marco G Patti
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

2.  Value of Multidetector Computed Tomography in the Assessment of Achalasia Subtypes and Detection of Pulmonary and Thoracic Complications.

Authors:  Sanja Jovanovic; Aleksandra Djuric-Stefanovic; Aleksandar Simić; Ognjan Skrobic; Predrag Pesko
Journal:  Med Princ Pract       Date:  2019-05-22       Impact factor: 1.927

3.  Upper esophageal sphincter abnormalities are strongly predictive of treatment response in patients with achalasia.

Authors:  Simon C Mathews; Maria Ciarleglio; Yamile Haito Chavez; John O Clarke; Ellen Stein; Bani Chander Roland
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

4.  The relationship between manometric subtype and outcomes of surgical treatment for patients with achalasia : Achalasia: manometric subtypes.

Authors:  Oscar Maximiliano Crespin; Roger Perry Tatum; Keliang Xiao; Ana Valeria Martin; Saurabh Khandelwal; Carlos Alberto Pellegrini; Brant Kurt Oelschlager
Journal:  Surg Endosc       Date:  2017-04-27       Impact factor: 4.584

Review 5.  Esophageal motility disorders on high-resolution manometry: Chicago classification version 4.0©.

Authors:  Rena Yadlapati; Peter J Kahrilas; Mark R Fox; Albert J Bredenoord; C Prakash Gyawali; Sabine Roman; Arash Babaei; Ravinder K Mittal; Nathalie Rommel; Edoardo Savarino; Daniel Sifrim; André Smout; Michael F Vaezi; Frank Zerbib; Junichi Akiyama; Shobna Bhatia; Serhat Bor; Dustin A Carlson; Joan W Chen; Daniel Cisternas; Charles Cock; Enrique Coss-Adame; Nicola de Bortoli; Claudia Defilippi; Ronnie Fass; Uday C Ghoshal; Sutep Gonlachanvit; Albis Hani; Geoffrey S Hebbard; Kee Wook Jung; Philip Katz; David A Katzka; Abraham Khan; Geoffrey Paul Kohn; Adriana Lazarescu; Johannes Lengliner; Sumeet K Mittal; Taher Omari; Moo In Park; Roberto Penagini; Daniel Pohl; Joel E Richter; Jordi Serra; Rami Sweis; Jan Tack; Roger P Tatum; Radu Tutuian; Marcelo F Vela; Reuben K Wong; Justin C Wu; Yinglian Xiao; John E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2021-01       Impact factor: 3.598

6.  Clinical, endoscopic, and radiologic features of three subtypes of achalasia, classified using high-resolution manometry.

Authors:  Mohammed Q Khan; Abdullah AlQaraawi; Fahad Al-Sohaibani; Khalid Al-Kahtani; Hamad I Al-Ashgar
Journal:  Saudi J Gastroenterol       Date:  2015 May-Jun       Impact factor: 2.485

7.  Comparison of the Outcomes of Peroral Endoscopic Myotomy for Achalasia According to Manometric Subtype.

Authors:  Won Hee Kim; Joo Young Cho; Weon Jin Ko; Sung Pyo Hong; Ki Baik Hahm; Jun-Hyung Cho; Tae Hee Lee; Su Jin Hong
Journal:  Gut Liver       Date:  2017-09-15       Impact factor: 4.519

8.  Clinical characteristics and treatment outcomes of 3 subtypes of achalasia according to the chicago classification in a tertiary institute in Korea.

Authors:  Ju Yup Lee; Nayoung Kim; Sung Eun Kim; Yoon Jin Choi; Kyu Keun Kang; Dong Hyun Oh; Hee Jin Kim; Kwung Jun Park; A Young Seo; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Jin-Hyeok Hwang; Jin-Wook Kim; Sook-Hyang Jeong; Dong Ho Lee
Journal:  J Neurogastroenterol Motil       Date:  2013-10-07       Impact factor: 4.924

9.  The early efficacy of Heller myotomy in the treatment of Iranian patients with achalasia.

Authors:  Saeed Abdi; Mojgan Forotan; Abdolrahim Nikzamir; Saeedeh Zomorody; Somayeh Jahani-Sherafat
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016

10.  The Reflux Symptoms Before and After Peroral Endoscopic Myotomy of Chinese Patients With Achalasia.

Authors:  Ying Xu; Yan Wang; Yun Bao; Ting Yu; Yurong Tang; Lin Lin; Liuqin Jiang
Journal:  J Neurogastroenterol Motil       Date:  2021-07-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.